Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI), most recent 12 months reported: net loss $10.52M. Latest balance sheet on file: liquid cash $22K, total debt $1.26M, net cash -$1.24M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Aura Biosciences, Inc. · ANAVEX LIFE SCIENCES CORP. · BIOATLA, INC. · BioCardia, Inc. · BLACK DIAMOND THERAPEUTICS, INC. · Black Hawk Acquisition Corporation · CABALETTA BIO, INC. · CANDEL THERAPEUTICS, INC.

Stock screener

Watchlist